JACKSON COOPER: Open Payments
NPI 1043056757 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,790 in 156 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $1,117 · 2025 $4,790
Food & beverage: $3,562Travel & lodging: $1,228
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. | 20 | $2,262 |
| GlaxoSmithKline, LLC. | 46 | $814 |
| AstraZeneca Pharmaceuticals LP | 23 | $468 |
| GENZYME CORPORATION | 12 | $255 |
| Mallinckrodt Hospital Products Inc. | 11 | $226 |
| Verona Pharma, Inc. | 15 | $218 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $178 |
| Regeneron Healthcare Solutions, Inc. | 5 | $114 |
| Merck Sharp & Dohme LLC | 5 | $79 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $52 |
Products named: INSPIRE, NUCALA, TRELEGY ELLIPTA, DUPIXENT, ACTHAR, TEZSPIRE, Ohtuvayre, AIRSUPRA.
Industry payments across MS — which companies pay providers there.
